Looking Back: 2020 Year in Review, part 4
: Johnson & Johnson halts recruitment for its phase 3 ENSEMBLE trial for its COVID-19 vaccine halts vaccine trial over a patient's unexplained illness but then restarted trials ag
: Johnson & Johnson halts recruitment for its phase 3 ENSEMBLE trial for its COVID-19 vaccine halts vaccine trial over a patient's unexplained illness but then restarted trials ag